You are here

Contact:
Mark Brager
202-434-7244
mbrager@advamed.org
October 28, 2015

AdvaMed Works with Evaluate to Provide AdvaMed Members Strategic Insights via EvaluateMedTech®

Christine Lindgren
Evaluate
617-866-3906
christine.lindgren@evaluategroup.com

The annual EvaluateMedTech World Preview report launched at AdvaMed 2015 in San Diego, CA showcasing the 2020 sector outlook.

LONDON, UK and WASHINGTON, DC (October 28, 2015) – Kenneth Mendez, chief administrative officer of the Advanced Medical Technology Association (AdvaMed) and Alexander Karle, CEO of life science market intelligence firm Evaluate Ltd today announced a collaboration to arrange for preferred medtech market intelligence services, which features insightful market intelligence via exclusive reports plus AdvaMed member discounts for the EvaluateMedTech service.

“EvaluateMedTech® offers value to AdvaMed members through its high-quality, timely coverage of the global medtech sector. It saves time spent on complex data aggregation and analyses which can inform critical business decisions more rapidly,” said Karle.

The EvaluateMedTech World Preview report provides a comprehensive annual industry analysis including segment sales and forecasts of the sector to 2020, as well as regulatory approvals, M&A, IPOs, venture financing and R&D spend of top companies. This complimentary report was launched at the AdvaMed 2015 conference, this year in San Diego. “We are honored to support AdvaMed member companies through the preferred provider program,” said  Karle. “We are committed to deliver AdvaMed members the highest quality, and most trusted medtech commercial intelligence available. Our focus is on our clients; their regular input and feedback drive our product innovation.”

Key Features of EvaluateMedTech® include:

·         Consensus Sales Forecasts to 2020

·         Company Segment Sales, Financials and Employee Numbers

·         M&A, Venture Financing and IPOs

·         Regulatory Approvals: Devices@FDA, CE Marks and PMDA (Japan)

·         R&D Spend and Clinical Trials

·         Company Device Portfolios: Marketed and R&D products

·         Epidemiology and Procedures Data

·         News, Commentary, Analysis and Special Reports

·         Merge Company and Peer Group Analyzer Tools

·         Workflow Support Tools

For more information please visit: www.evaluategroup.com/AdvaMed

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Our services include EvaluatePharmaEvaluateClinical Trials and EvaluateMedTech. Our award-winning editorial team, EP Vantage, leverages our strategic analysis to cut through the noise, giving you daily opinion and insights. The Evaluate services enable the life science community to make sound business decisions about value and opportunity. For more information please visit www.evaluategroup.comOn Twitter: @evaluatepharma, @evaluatemedtech, @evaluateJP, @epclinicaltrial, @epvantage.